Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Hodgkin Disease 21Lymphoma 13Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Urinary Bladder Neoplasms 5Testicular Neoplasms 3Prostatic Neoplasms 3Melanoma 3Urethral Neoplasms 2Testicular Germ Cell Tumor 2Teratoma 2Lymphoma, Large-Cell, Anaplastic 2Uterine Cervical Neoplasms 1Skin Neoplasms 1Seminoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Lymphoma, Large B-Cell, Diffuse 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1Adenocarcinoma of Lung 1

Interventions

Dacarbazine 4pembrolizumab 3binimetinib 3Nivolumab 3encorafenib 2cemiplimab 2Sirolimus 2Ipilimumab 2vitespin 1trametinib 1tilsotolimod 1spartalizumab 1oblimersen 1linrodostat 1lifileucel 1gp100 Melanoma Antigen 1dabrafenib 1bempegaldesleukin 1aldesleukin 1Vinblastine 1Vemurafenib 1Tretinoin 1Tacrolimus 1Standard of Care 1Sodium Chloride 1Radiotherapy 1Radiation 1Interleukin-2 1Interferon-alpha 1Interferon alpha-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Skin Neoplasms × Vinblastine × Clear all
NCT00002882 2011-12-13

Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma

M.D. Anderson Cancer Center

Phase 3 Completed
140 enrolled
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡